Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy

MLA

Bruno Valentin Sinn, et al. “Human Leucocyte Antigen Class I in Hormone Receptor-Positive, HER2-Negative Breast Cancer: Association with Response and Survival after Neoadjuvant Chemotherapy.” Breast Cancer Research, vol. 21, no. 1, Dec. 2019, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s13058-019-1231-z.

APA

Bruno Valentin Sinn, Karsten E. Weber, Wolfgang Daniel Schmitt, Peter A. Fasching, William Fraser Symmans, Jens-Uwe Blohmer, Thomas Karn, Eliane Tabea Taube, Frederick Klauschen, Frederik Marmé, Christian Schem, Elmar Stickeler, Beyhan Ataseven, Jens Huober, Gunter von Minckwitz, Barbara Seliger, Carsten Denkert, & Sibylle Loibl. (2019). Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy. Breast Cancer Research, 21(1), 1–9. https://doi.org/10.1186/s13058-019-1231-z

Chicago

Bruno Valentin Sinn, Karsten E. Weber, Wolfgang Daniel Schmitt, Peter A. Fasching, William Fraser Symmans, Jens-Uwe Blohmer, Thomas Karn, et al. 2019. “Human Leucocyte Antigen Class I in Hormone Receptor-Positive, HER2-Negative Breast Cancer: Association with Response and Survival after Neoadjuvant Chemotherapy.” Breast Cancer Research 21 (1): 1–9. doi:10.1186/s13058-019-1231-z.